| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 304.37M | 278.42M | 259.48M | 230.57M | 204.96M | 173.34M |
| Gross Profit | 99.79M | 89.45M | 83.81M | 68.36M | 58.44M | 46.12M |
| EBITDA | 42.68M | 37.69M | 33.82M | 26.86M | 23.57M | 18.65M |
| Net Income | 13.48M | 14.52M | 13.65M | 10.69M | 11.38M | 7.79M |
Balance Sheet | ||||||
| Total Assets | 484.89M | 385.24M | 287.55M | 195.75M | 177.76M | 132.12M |
| Cash, Cash Equivalents and Short-Term Investments | 5.08M | 1.52M | 35.18M | 1.53M | 1.40M | 560.00K |
| Total Debt | 143.78M | 57.73M | 21.54M | 64.41M | 57.65M | 27.52M |
| Total Liabilities | 189.47M | 98.36M | 62.38M | 96.12M | 91.59M | 57.04M |
| Stockholders Equity | 295.42M | 286.88M | 225.17M | 99.63M | 86.18M | 75.08M |
Cash Flow | ||||||
| Free Cash Flow | 25.11M | 25.79M | 19.34M | 7.54M | 7.47M | 17.02M |
| Operating Cash Flow | 39.70M | 38.98M | 32.62M | 16.95M | 17.62M | 23.64M |
| Investing Cash Flow | -167.60M | -84.00M | -41.67M | -18.51M | -39.85M | -10.15M |
| Financing Cash Flow | 109.40M | 26.86M | 27.40M | 876.00K | 23.69M | -12.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $1.09B | 16.19 | 22.61% | 3.66% | 0.16% | 2.99% | |
71 Outperform | $1.51B | 18.30 | 19.58% | ― | 12.76% | 36.11% | |
65 Neutral | $504.39M | 44.48 | 4.02% | ― | 11.81% | -39.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $1.27B | ― | -1.68% | ― | 14.46% | -588.82% | |
54 Neutral | $354.66M | 56.41 | 3.77% | ― | 12.63% | -21.23% | |
51 Neutral | $383.78M | -6.08 | -9.63% | ― | -8.92% | ― |
The recent earnings call for Transcat painted a picture of robust growth tempered by some challenges. The general sentiment was positive, with strong revenue growth and successful acquisitions taking center stage. However, this optimism was slightly offset by a decline in net income due to increased expenses and economic uncertainties impacting the service segment.
Transcat, Inc. is a prominent provider of calibration, reliability, and maintenance optimization services, primarily serving the life sciences, aerospace, defense, energy, and utilities sectors. The company also operates as a value-added distributor of test and measurement instruments across North America.
Transcat, Inc. has announced the retirement of Scott D. Deverell as corporate controller and principal accounting officer, effective September 10, 2025. Kristina Johnston, who has been with the company since June 2025, will assume the role. Johnston brings extensive experience from her previous roles at Vintage Wine Estates, Inc. and Constellation Brands, Inc. Additionally, at the annual meeting on September 10, 2025, shareholders elected new directors, approved executive compensation measures, and ratified Deloitte & Touche LLP as the independent accounting firm for the fiscal year ending March 28, 2026. The board also decided to hold annual advisory votes on executive compensation.
The most recent analyst rating on (TRNS) stock is a Hold with a $88.00 price target. To see the full list of analyst forecasts on Transcat stock, see the TRNS Stock Forecast page.
On August 21, 2025, Transcat, Inc. announced a transition plan for CEO Lee D. Rudow, who will retire in March 2026 and then serve as a strategic advisor until 2027. The board has initiated a search for a new CEO, and Rudow’s leadership has been credited with significant growth and acquisitions, positioning the company for a strong future. The company has reiterated a positive outlook for fiscal 2026, highlighting recent financial performance and strategic acquisitions, which are expected to enhance market share and drive organic revenue growth.
The most recent analyst rating on (TRNS) stock is a Buy with a $111.00 price target. To see the full list of analyst forecasts on Transcat stock, see the TRNS Stock Forecast page.